By Kat Black | September 18, 2024
The complaint, filed by Almeida Law Group and Siri & Glimstad on Aug. 1 in the U.S. District Court for the Central District of California, alleges violations of the Electronic Communications Privacy Act and the California Invasion of Privacy Act; invasion of privacy - intrusion upon seclusion; and unjust enrichment.
By Michelle Morgante | August 23, 2024
Former CVS executive Adam Korn allegedly divulged confidential information about the company's reimbursement practices to support a suit filed by the Chickasaw Nation.
By Michelle Morgante | August 22, 2024
California-based Amgen has filed a patent infringement suit to stop Samsung Bioepis from developing bone-treatment drugs that would rival two of its top-performing products.
By Sulaiman Abdur-Rahman | August 9, 2024
"A 50-mg dose of Enbrel now costs patients $7,401.83 per month: 643% more than it cost when launched in 1998," according to the allegations in the antitrust class action filed against Enbrel manufacturer Amgen Inc.
By Kat Black | June 11, 2024
A $700 million settlement reached by Johnson & Johnson with attorneys general from 43 states prohibits the pharmaceutical company from manufacturing, selling or distributing its talcum-based body powder products, which are known to increase the risk for cancer, in the United States.
By Amanda Bronstad | May 23, 2024
An Illinois jury sided with pharmaceutical manufacturers GlaxoSmithKline and Boehringer Ingelheim in the first verdict in the Zantac litigation.
By Allison Dunn | May 22, 2024
"Bayer is pleased with the plaintiff's decision to voluntarily dismiss these meritless claims against the Company in Sidhu and believes that the replicated claims raised in the Copeland filing are equally baseless," the company said in a statement. "The Company continues to stand behind the safety of the product that is supported by extensive scientific evidence."
By Brian Lee | May 3, 2024
The settlement in principle accounts for New Jersey-based Amneal's role in fueling the national epidemic of opioid addictions and overdoses, New York and California said in separate statements.
The Legal Intelligencer | News
By Amanda Bronstad | April 4, 2024
Plaintiffs lawyers who assembled a proposed leadership team in Ozempic lawsuits fired back at the accusation that they excluded attorneys—then added two more lawyers to their proposed team.
By Amanda Bronstad | April 3, 2024
Plaintiffs lawyers in the Ozempic multidistrict litigation organized a leadership team of 30 attorneys, but one Florida attorney objected to the proposed slate, which she says appears to be composed of 'repeat players.'
Presented by BigVoodoo
Women, Influence & Power in Law Awards honors women lawyers who have made a remarkable difference in the legal profession.
WIPL is the original global forum facilitating women-to-women exchange on leadership and legal issues.
The New England Legal Awards serves as a testament to the outstanding contributions and achievements made by legal professionals.
A prominent AV-rated Education Law firm seeks an associate with 5+ years experience. The role will primarily involve advice and counsel in ...
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Javerbaum Wurgaft, a large civil litigation firm with nine (9) offices, seeks: Plaintiff Personal Injury Attorney for Northern New Jersey of...